2026 Clinical Review on Cancer Rehab

Beyond Survival: Why Cancer Rehabilitation Must Catch Up to Modern Oncology

By Ben Ho Park, MD, PhD, Breast Oncologist

Cancer care has entered a remarkable era of innovation. Today’s therapies are more targeted, more personalized, and in many cases more effective than ever before. Patients are living longer, surviving more complex disease, and benefiting from breakthroughs that would have been unimaginable a generation ago. But with this progress comes a new and urgent reality: many of the newest cancer therapies are leaving behind a different kind of burden—one that doesn’t always end when treatment does.

For decades, the conversation around cancer recovery has focused heavily on surgery, chemotherapy, and radiation. While these remain major contributors to long-term morbidity, the landscape has changed. Modern oncology now includes immunotherapy, targeted therapies, HER2-directed treatments, stem cell and bone marrow transplants, and other precision-based interventions that can profoundly alter a patient’s physiology. These treatments are saving lives—but they are also creating a growing population of survivors living with chronic and sometimes permanent complications.

This is exactly why rehabilitation in cancer care must evolve.

As Dr. Ben Ho Park points out, “with all these great new therapies come also and unfortunately, new chronic side effects.” That statement captures a major blind spot in survivorship medicine. Too often, the success of treatment is measured only by tumor response or remission status, while the patient’s long-term functional decline, organ injury, or inflammatory burden remains underrecognized.

Immunotherapy is a powerful example. These agents have transformed the outlook for many cancers by enabling the immune system to attack malignant cells more effectively. Yet they can also trigger immune-related adverse effects that persist long after treatment is over. Some patients may experience permanent damage to endocrine organs such as the adrenal glands, thyroid, or pancreas—conditions that can fundamentally alter metabolism, energy regulation, and quality of life. What may begin as a treatment response can ultimately become a lifelong endocrine disorder requiring ongoing management and monitoring.

Similarly, bone marrow and stem cell transplant survivors often face one of the most difficult chronic complications in oncology: graft-versus-host disease (GVHD). In its chronic form, GVHD can behave like a systemic autoimmune illness, affecting the skin, lungs, joints, gastrointestinal tract, eyes, and connective tissues. In some patients, it can resemble diseases such as scleroderma in both symptoms and severity. These are not minor residual effects. They can impair mobility, breathing, digestion, resilience, and the basic ability to function comfortably in everyday life.

Other newer therapies bring their own risks. HER2-directed therapies, while highly effective in breast and other HER2-positive cancers, can in some cases contribute to cardiac dysfunction or heart failure. Additional targeted therapies may affect vascular health, nerve function, inflammatory pathways, or organ performance in ways that are not always immediately visible—but are deeply felt by patients over time.

This is where RehabScan enters the conversation with urgency and relevance.

If cancer treatment is becoming more biologically sophisticated, then rehabilitation must become more diagnostically sophisticated as well. Recovery should no longer be defined only by symptom complaints or generalized supportive care. It should include a structured, measurable effort to identify what systems have been altered, what damage may be lingering beneath the surface, and what interventions can help restore function before decline becomes permanent.

Cancer survivorship is no longer just about being alive after treatment. It is about how well a person is able to live, function, think, move, recover, and reclaim quality of life after the therapies that saved them. The next frontier in oncology is not just better treatment—it is better restoration.

And for many survivors, that may be the care that matters most.

 

PART 2

Redefining Cancer Recovery through Diagnostic Intelligence

By: Dr. Robert L. Bard, Barddiagnostics, NYC

Cancer treatment saves lives—but survival is only the beginning. For millions of patients worldwide, the journey after chemotherapy, radiation, surgery, or immunotherapy is marked not by recovery, but by a new and often overwhelming set of chronic conditions. These are not incidental side effects. They are measurable, evolving physiological disruptions that affect nearly every system of the body. RehabScan™ is designed to meet this moment. It is a next-generation, imaging-supported rehabilitation ecosystem that introduces objective diagnostics into the recovery phase of cancer care, transforming rehabilitation from generalized protocols into precision-guided restoration.

REBUILDING LIFE AFTER CANCER: The Transformative Work of Oncology Rehabilitation

In the evolving landscape of cancer care, survival is no longer the sole benchmark of success. Increasingly, the conversation has shifted toward how patients live after treatment—how they speak, move, eat, think, and reclaim independence. At the forefront of this critical shift is Kaitlin Pennington, an Oncology Rehabilitation Specialist and Founder & CEO of Cancer Rehab Group and Restorative Health & Wellness, whose work is redefining what recovery truly means.

For Pennington, cancer rehabilitation is not an optional service—it is an essential extension of treatment. As she explains through her clinical philosophy, rehabilitation must begin at the moment of diagnosis, not after treatment ends. Baseline function, risk assessment, and proactive intervention are key to preserving quality of life. “It’s critical that it starts at the time of diagnosis,” she emphasizes, noting that early intervention can significantly reduce long-term functional decline .

Rehabilitation as a Missing Link in Cancer Care

Modern cancer treatments, while life-saving, can be profoundly taxing on the body. Radiation fibrosis, surgical trauma, neurological changes, and systemic side effects often leave patients struggling with basic functions long after treatment ends. Pennington’s work addresses this overlooked phase—the “aftermath” of cancer therapy. Her approach integrates:

· Speech and swallowing rehabilitation

· Physical and occupational therapy

· Nutritional guidance

· Mental health support

· Exercise oncology

Together, these disciplines form a comprehensive system designed not only to restore function but to prevent deterioration. The need is urgent. Many patients, particularly those treated years ago, were never offered rehabilitation. They adapt to dysfunction, believing it is irreversible. Pennington challenges this assumption daily.

PART 3

REHAB FOR POSTOP PATIENTS

By Cheri Ambrose (Op-Ed) - Male Breast Cancer Global Alliance

There are more cancer survivors today than ever before—and that should be a victory worth celebrating. But what we don’t talk about enough is the condition of those survivors after treatment ends. Too many are left navigating a quiet aftermath: a body that doesn’t function the way it used to, a mind that feels unfamiliar, and a life that has been altered in ways no one fully prepared them for.

We have spent decades focused on detection and treatment. We’ve made extraordinary strides in saving lives. But survival is not the finish line—it is the beginning of a new phase that demands just as much attention. And right now, that phase is underserved, underfunded, and misunderstood.

 I’ve spoken to countless patients—men and women—who are told, “This is just what happens after chemo.” They are expected to accept neuropathy, chronic fatigue, cognitive impairment, emotional distress, and hormonal disruption as the cost of survival. But I reject that. We should all reject that. Because survival without quality of life is not enough. We need to redefine what rehabilitation truly means in cancer care.

Traditionally, rehab has been reduced to physical therapy—range of motion, strength building, and basic function. But what I see every day tells a very different story. Post-treatment patients are dealing with multi-system damage. They are struggling with what we call “chemo brain,” where memory, focus, and clarity are compromised. They are experiencing neuropathy that affects their ability to walk, drive, or even hold a pen. They are facing lymphedema that alters their physical comfort and confidence. And many are quietly battling depression, anxiety, and loss of identity.

REDEFINING REHAB FOR POSTOP PATIENTS

CANCER REHABILITATION AND THE FIGHT AGAINST RECURRENCE

By Cheri Ambrose (Op-Ed) - Male Breast Cancer Global Alliance

 

There are more cancer survivors today than ever before—and that should be a victory worth celebrating. But what we don’t talk about enough is the condition of those survivors after treatment ends. Too many are left navigating a quiet aftermath: a body that doesn’t function the way it used to, a mind that feels unfamiliar, and a life that has been altered in ways no one fully prepared them for.

 

We have spent decades focused on detection and treatment. We’ve made extraordinary strides in saving lives. But survival is not the finish line—it is the beginning of a new phase that demands just as much attention. And right now, that phase is underserved, underfunded, and misunderstood.

 

I’ve spoken to countless patients—men and women—who are told, “This is just what happens after chemo.” They are expected to accept neuropathy, chronic fatigue, cognitive impairment, emotional distress, and hormonal disruption as the cost of survival. But I reject that. We should all reject that. Because survival without quality of life is not enough. We need to redefine what rehabilitation truly means in cancer care.

 

Traditionally, rehab has been reduced to physical therapy—range of motion, strength building, and basic function. But what I see every day tells a very different story. Post-treatment patients are dealing with multi-system damage. They are struggling with what we call “chemo brain,” where memory, focus, and clarity are compromised. They are experiencing neuropathy that affects their ability to walk, drive, or even hold a pen. They are facing lymphedema that alters their physical comfort and confidence. And many are quietly battling depression, anxiety, and loss of identity.

 

As I’ve said before, it’s not good enough to simply acknowledge these side effects—we have to address them head-on and give people tools to live better with them.  This is why I believe it’s time to expand rehabilitation into something more comprehensive: restorative care.

 

Restorative care recognizes that recovery is not just about muscles and mobility—it’s about restoring systems, function, and dignity. It means integrating solutions that target neurological health, vascular function, endocrine balance, lymphatic drainage, and emotional resilience. It means bringing together clinicians, therapists, and innovative practitioners who understand that healing is layered and interconnected. And perhaps most importantly, it means giving patients hope—not false hope, but real, actionable pathways toward improvement.

 

Let’s talk about chemobrain for a moment. This is one of the most frustrating and misunderstood consequences of cancer treatment. Patients describe it as a fog they can’t shake. They forget words mid-sentence. They lose track of conversations. They struggle to perform tasks they once did effortlessly. And yet, too often, it is minimized or dismissed.

 

But chemobrain is real. And it deserves real solutions. The same goes for neuropathy. I know patients who can no longer feel their feet properly, who rely on cruise control to drive because they can’t trust their own reflexes. This isn’t a minor inconvenience—this is life-altering. It affects independence, safety, and self-worth.

 

Then there’s the emotional toll. Cancer doesn’t just attack the body—it reshapes identity. For men with breast cancer, there is an added layer of isolation and stigma. They are often not prepared for the hormonal changes, the sexual dysfunction, or the psychological impact of navigating what is still widely perceived as a “female disease.” These are not small issues. They are central to a person’s sense of self. And yet, we continue to treat them as secondary.

 

At the same time, we cannot ignore the looming concern of recurrence. Survivors are not just recovering—they are living with the constant question: “Will it come back?” That fear is real, and it should be met with proactive strategies, not passive reassurance.

 

This is where restorative care intersects with prevention. When we support the body’s systems—when we reduce inflammation, improve circulation, enhance detoxification pathways, and monitor changes through advanced diagnostics—we are not just improving quality of life. We are creating an environment that is less conducive to disease recurrence. And that brings me to something I believe deserves far more attention: the role of detoxification professionals.

 

Now, let me be clear—this is not about replacing conventional medicine. It’s about complementing it. After chemotherapy, the body is burdened with the byproducts of powerful treatments. Supporting the liver, kidneys, lymphatic system, and metabolic processes is not fringe thinking—it is logical, necessary care. I’ve seen what happens when patients are given access to integrative detox strategies—whether it’s sauna therapy, guided protocols, or targeted support for elimination pathways. They feel better. They think more clearly. They regain energy. And most importantly, they feel like they have some control again.

 That’s why I am advocating for the formation of an Alliance for Rehab Professionals—a collaborative network of experts dedicated to supporting post-treatment recovery in a safe, evidence-informed, and patient-centered way. We need structure. We need standards. And we need to bring these professionals into the broader conversation about survivorship. Because the truth is, no single discipline has all the answers. But together, we can build something better. We can create a model of care that doesn’t end when treatment ends. We can support survivors not just in living—but in living well. We can redefine rehabilitation as a dynamic, ongoing process of restoration, resilience, and renewal. And we can finally give cancer survivors what they truly deserve: Not just more years of life—but better life in those years.